UN Warns of Health Dangers in Commercial Psychedelic Drug Use [BNN Bloomberg (Canada)]
Mind Medicine (MindMed) Inc. - Common Shares (MNMD)
Company Research
Source: BNN Bloomberg
Public interest in and private sector attention to psychedelic therapies are greater than the scientific evidence regarding their effectiveness in improving mental health and cognitive functions, the UN Office on Drugs and Crime said in its annual report on Wednesday. “The risk is that the perception of psychedelics as the ‘silver bullet' for mental health disorders and overall mental or spiritual well-being, which is advocated for by a growing number of advocacy groups and commercial interests, will move faster than scientific evidence,” the UN researchers wrote. The report comes as more companies promote psychedelic therapies. About 15% of the 1,300 psychedelic clinical trials worldwide identified in the report are funded by industry, with the rest backed by public health agencies or education institutions Mind Medicine Inc., or MindMed, GH Research Plc and Atai Life Sciences NV are among the publicly listed companies that have captured the attention of investors in the $15 b
Show less
Read more
Impact Snapshot
Event Time:
MNMD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MNMD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MNMD alerts
High impacting Mind Medicine (MindMed) Inc. - Common Shares news events
Weekly update
A roundup of the hottest topics
MNMD
News
- MindMed to be Included in Russell 2000® and Russell 3000® IndexesBusiness Wire
- Startup's ‘Fentanyl Vaccine' Aims to Block Drug's Highs, Overdoses [BNN Bloomberg (Canada)]BNN Bloomberg
- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.MarketBeat
- MindMed to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual ConferenceBusiness Wire
- MindMed Announces Constructive End-of-Phase 2 Meeting with U.S. FDA for MM120 in Generalized Anxiety Disorder (GAD)Business Wire
MNMD
Earnings
- 5/8/24 - Miss
MNMD
Sec Filings
- 6/28/24 - Form 8-K
- 6/28/24 - Form S-3ASR
- 6/28/24 - Form S-8
- MNMD's page on the SEC website